Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04216732 · ClinicalTrials.gov registry record
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
A clinical trial of Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 and Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 2,030
- Enrollment target
- 2
- Study locations
NCT04216732: Recruiting study of Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 and Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, sponsored by M.D. Anderson Cancer Center.
NCT04216732 is a study of Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 and Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,030 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04216732, a study of Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 and Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 2,030 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.
Primary Outcome
Will describe the natural history of MTC using comprehensive battery of demographic, clinical, pathologic, and genotypic variables collected in existing multi-institutional patient registry.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Blood Pressure Measurement
Study Locations (2)
California
- University of California San Francisco - San Francisco
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,030 participants |
| Start Date | 2020-01-10 |
| Est. Completion | 2026-09-01 |
What NCT04216732 shows while recruiting
NCT04216732 is an observational study that tracks outcomes without assigning an intervention. Its 2,030 participants enrollment target places it among the larger protocols in the corpus.
The record links to 6 conditions, with Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT04216732 reports a single indexed study location in California, Texas.
Frequently Asked Questions
What is clinical trial NCT04216732 about?
NCT04216732 is a clinical study titled "Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management". This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn ab...
What is the current status of trial NCT04216732?
This trial is currently recruiting. The enrollment target is 2,030 participants. The study started on 2020-01-10. Estimated completion is 2026-09-01.
What conditions does trial NCT04216732 study?
This clinical trial studies the following conditions: Stage IV Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8, Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8, Advanced Thyroid Gland Medullary Carcinoma.
What interventions are being tested in trial NCT04216732?
The interventions under investigation include: Questionnaire Administration (OTHER), Blood Pressure Measurement (OTHER).
Who is sponsoring clinical trial NCT04216732?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04216732 being conducted?
This trial has 2 study locations across California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IV Thyroid Gland Medullary Carcinoma AJCC v8
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
- NCT06825897 · 2,039 participants · NA
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI